STAAR Surgical Cash Flow from Financial Activities 2012-2026 | STAA
STAAR Surgical cash flow from financial activities from 2012 to 2026. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
|
STAAR Surgical Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2025 | $-5 |
| 2024 | $6 |
| 2023 | $7 |
| 2022 | $8 |
| 2021 | $18 |
| 2020 | $20 |
| 2019 | $0 |
| 2018 | $75 |
| 2017 | $2 |
| 2016 | $3 |
| 2015 | $5 |
| 2014 | $3 |
| 2013 | $2 |
| 2012 | $4 |
| 2011 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $1.309B | $0.239B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |